

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.53833185 |
| 2 | exogenous drug catabolic process (GO:0042738) | 7.77037727 |
| 3 | drug catabolic process (GO:0042737) | 7.55036341 |
| 4 | drug metabolic process (GO:0017144) | 6.33139980 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 6.31011262 |
| 6 | cellular glucuronidation (GO:0052695) | 6.03861004 |
| 7 | uronic acid metabolic process (GO:0006063) | 5.85600753 |
| 8 | glucuronate metabolic process (GO:0019585) | 5.85600753 |
| 9 | angiotensin maturation (GO:0002003) | 5.81502032 |
| 10 | regulation of triglyceride catabolic process (GO:0010896) | 5.59650146 |
| 11 | ethanol oxidation (GO:0006069) | 5.54723799 |
| 12 | bile acid and bile salt transport (GO:0015721) | 5.37493185 |
| 13 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.30778528 |
| 14 | urea metabolic process (GO:0019627) | 5.10194542 |
| 15 | alkaloid metabolic process (GO:0009820) | 5.02713037 |
| 16 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.00126259 |
| 17 | intestinal absorption (GO:0050892) | 4.84444148 |
| 18 | bile acid metabolic process (GO:0008206) | 4.84148233 |
| 19 | glyoxylate metabolic process (GO:0046487) | 4.81284553 |
| 20 | nitrogen cycle metabolic process (GO:0071941) | 4.67218602 |
| 21 | oxidative demethylation (GO:0070989) | 4.66861511 |
| 22 | L-phenylalanine catabolic process (GO:0006559) | 4.60139697 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.60139697 |
| 24 | hormone catabolic process (GO:0042447) | 4.57298134 |
| 25 | urea cycle (GO:0000050) | 4.53386277 |
| 26 | flavonoid metabolic process (GO:0009812) | 4.51108981 |
| 27 | arginine metabolic process (GO:0006525) | 4.45330887 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.45033367 |
| 29 | phenylpropanoid metabolic process (GO:0009698) | 4.38463350 |
| 30 | ethanol metabolic process (GO:0006067) | 4.38394703 |
| 31 | complement activation, alternative pathway (GO:0006957) | 4.30328291 |
| 32 | regulation of guanylate cyclase activity (GO:0031282) | 4.15100028 |
| 33 | L-phenylalanine metabolic process (GO:0006558) | 4.10124716 |
| 34 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.10124716 |
| 35 | lipoprotein transport (GO:0042953) | 4.09145538 |
| 36 | regulation of protein activation cascade (GO:2000257) | 4.07952254 |
| 37 | regulation of bile acid biosynthetic process (GO:0070857) | 4.04420361 |
| 38 | bile acid biosynthetic process (GO:0006699) | 3.98782321 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 3.95393377 |
| 40 | aromatic amino acid family catabolic process (GO:0009074) | 3.93210493 |
| 41 | regulation of fibrinolysis (GO:0051917) | 3.92372002 |
| 42 | regulation of complement activation (GO:0030449) | 3.90927964 |
| 43 | negative regulation of sterol transport (GO:0032372) | 3.80828396 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 3.80828396 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 3.76095198 |
| 46 | macromolecular complex remodeling (GO:0034367) | 3.76095198 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 3.76095198 |
| 48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.75060735 |
| 49 | heme transport (GO:0015886) | 3.72430394 |
| 50 | vitamin biosynthetic process (GO:0009110) | 3.68163863 |
| 51 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.65958724 |
| 52 | fructose metabolic process (GO:0006000) | 3.63880399 |
| 53 | drug transmembrane transport (GO:0006855) | 3.59792920 |
| 54 | phospholipid efflux (GO:0033700) | 3.58144146 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 3.56825330 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 3.56730521 |
| 57 | triglyceride homeostasis (GO:0070328) | 3.55514994 |
| 58 | acylglycerol homeostasis (GO:0055090) | 3.55514994 |
| 59 | reverse cholesterol transport (GO:0043691) | 3.55320305 |
| 60 | S-adenosylmethionine metabolic process (GO:0046500) | 3.53188794 |
| 61 | negative regulation of fibrinolysis (GO:0051918) | 3.50585296 |
| 62 | regulation of cholesterol esterification (GO:0010872) | 3.49705770 |
| 63 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.48923388 |
| 64 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48923388 |
| 65 | positive regulation of lipid catabolic process (GO:0050996) | 3.48287830 |
| 66 | NADH metabolic process (GO:0006734) | 3.47170756 |
| 67 | xenobiotic metabolic process (GO:0006805) | 3.45209197 |
| 68 | drug transport (GO:0015893) | 3.42558181 |
| 69 | lipoprotein metabolic process (GO:0042157) | 3.34012890 |
| 70 | diacylglycerol metabolic process (GO:0046339) | 3.33855053 |
| 71 | tryptophan catabolic process (GO:0006569) | 3.33717866 |
| 72 | indole-containing compound catabolic process (GO:0042436) | 3.33717866 |
| 73 | indolalkylamine catabolic process (GO:0046218) | 3.33717866 |
| 74 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.33542162 |
| 75 | endocrine process (GO:0050886) | 3.33542162 |
| 76 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.33542162 |
| 77 | complement activation, classical pathway (GO:0006958) | 3.32553386 |
| 78 | urate metabolic process (GO:0046415) | 3.27753743 |
| 79 | blood coagulation, intrinsic pathway (GO:0007597) | 3.23195497 |
| 80 | protein activation cascade (GO:0072376) | 3.22775159 |
| 81 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.21747814 |
| 82 | renal system process involved in regulation of blood volume (GO:0001977) | 3.19349860 |
| 83 | negative regulation of blood coagulation (GO:0030195) | 3.18301324 |
| 84 | negative regulation of hemostasis (GO:1900047) | 3.18301324 |
| 85 | serine family amino acid catabolic process (GO:0009071) | 3.17224596 |
| 86 | cholesterol efflux (GO:0033344) | 3.16622268 |
| 87 | protein carboxylation (GO:0018214) | 3.14617726 |
| 88 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.14617726 |
| 89 | complement activation (GO:0006956) | 3.14140048 |
| 90 | ketone body metabolic process (GO:1902224) | 3.09741788 |
| 91 | vitamin transport (GO:0051180) | 3.09536334 |
| 92 | coenzyme catabolic process (GO:0009109) | 3.07174464 |
| 93 | phospholipid homeostasis (GO:0055091) | 3.07012998 |
| 94 | fibrinolysis (GO:0042730) | 3.06214078 |
| 95 | homocysteine metabolic process (GO:0050667) | 3.03531692 |
| 96 | glycerol metabolic process (GO:0006071) | 3.02660594 |
| 97 | primary alcohol metabolic process (GO:0034308) | 3.02288005 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.01876097 |
| 99 | plasma lipoprotein particle organization (GO:0071827) | 3.01843198 |
| 100 | intestinal cholesterol absorption (GO:0030299) | 3.01014485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.04760346 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.08468842 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.43276677 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.23627019 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.95111976 |
| 6 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.82220902 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.46171400 |
| 8 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.28624707 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.23600852 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01208355 |
| 11 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.99642052 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.93404050 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.91352839 |
| 14 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.89819334 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.81955029 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.81853539 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 1.78803542 |
| 18 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.71284183 |
| 19 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.69166865 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.58209158 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.55436011 |
| 22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.54365003 |
| 23 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.48126246 |
| 24 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.45883531 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45647140 |
| 26 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43651404 |
| 27 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43402740 |
| 28 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42650925 |
| 29 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35361955 |
| 30 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.32963878 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32555085 |
| 32 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.30336438 |
| 33 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.26951887 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25232833 |
| 35 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.25203076 |
| 36 | AR_20517297_ChIP-Seq_VCAP_Human | 1.24703664 |
| 37 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.24176139 |
| 38 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.23848450 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22721596 |
| 40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22041603 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21937464 |
| 42 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21931894 |
| 43 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.21658887 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20946550 |
| 45 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.20847671 |
| 46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20784389 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17741657 |
| 48 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17606669 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.17299735 |
| 50 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.16936285 |
| 51 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.15626282 |
| 52 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14286475 |
| 53 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13022592 |
| 54 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.12196203 |
| 55 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.12196203 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.08582494 |
| 57 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07780871 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05685045 |
| 59 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.05538847 |
| 60 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05311395 |
| 61 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03095378 |
| 62 | NCOR_22424771_ChIP-Seq_293T_Human | 1.01425253 |
| 63 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00744564 |
| 64 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00744564 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00452251 |
| 66 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99230460 |
| 67 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.96919618 |
| 68 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.96868138 |
| 69 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96095714 |
| 70 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.95672207 |
| 71 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95625472 |
| 72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94789701 |
| 73 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.93406682 |
| 74 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93189599 |
| 75 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.92905038 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92692253 |
| 77 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.92062022 |
| 78 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.91940425 |
| 79 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.91489771 |
| 80 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.91378665 |
| 81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91233274 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90941837 |
| 83 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90941837 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90901652 |
| 85 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89957352 |
| 86 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89659978 |
| 87 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.89612026 |
| 88 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.88928270 |
| 89 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88904056 |
| 90 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88253701 |
| 91 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88162343 |
| 92 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.88020339 |
| 93 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.88016231 |
| 94 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.87364831 |
| 95 | NFYA_21822215_ChIP-Seq_K562_Human | 0.86721168 |
| 96 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85984108 |
| 97 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.85588527 |
| 98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85058582 |
| 99 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.84944477 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84847940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.07265591 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.87128794 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.85257123 |
| 4 | MP0005365_abnormal_bile_salt | 5.01948274 |
| 5 | MP0001666_abnormal_nutrient_absorption | 4.27175145 |
| 6 | MP0003195_calcinosis | 3.83692763 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.50317929 |
| 8 | MP0003252_abnormal_bile_duct | 3.29631571 |
| 9 | MP0004019_abnormal_vitamin_homeostasis | 3.12925699 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.96518200 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.90814187 |
| 12 | MP0005332_abnormal_amino_acid | 2.68346514 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.60295647 |
| 14 | MP0003868_abnormal_feces_composition | 2.59214796 |
| 15 | MP0004147_increased_porphyrin_level | 2.47362255 |
| 16 | MP0002876_abnormal_thyroid_physiology | 2.40902891 |
| 17 | MP0009840_abnormal_foam_cell | 2.35044680 |
| 18 | MP0004043_abnormal_pH_regulation | 2.17840803 |
| 19 | MP0009643_abnormal_urine_homeostasis | 1.92822576 |
| 20 | MP0001764_abnormal_homeostasis | 1.92066078 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.68740858 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 1.56045084 |
| 23 | MP0005636_abnormal_mineral_homeostasis | 1.51023061 |
| 24 | MP0005670_abnormal_white_adipose | 1.47332681 |
| 25 | MP0009379_abnormal_foot_pigmentation | 1.46544043 |
| 26 | MP0008872_abnormal_physiological_respon | 1.44418736 |
| 27 | MP0001756_abnormal_urination | 1.38604434 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.36853470 |
| 29 | MP0000609_abnormal_liver_physiology | 1.31633370 |
| 30 | MP0004264_abnormal_extraembryonic_tissu | 1.28634372 |
| 31 | MP0003879_abnormal_hair_cell | 1.28620922 |
| 32 | MP0001664_abnormal_digestion | 1.26449433 |
| 33 | MP0001765_abnormal_ion_homeostasis | 1.25603994 |
| 34 | MP0000538_abnormal_urinary_bladder | 1.23944451 |
| 35 | MP0002136_abnormal_kidney_physiology | 1.18737343 |
| 36 | MP0003866_abnormal_defecation | 1.13233316 |
| 37 | MP0005535_abnormal_body_temperature | 1.12452452 |
| 38 | MP0009697_abnormal_copulation | 1.11339881 |
| 39 | MP0005448_abnormal_energy_balance | 1.07108639 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.02372468 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02242303 |
| 42 | MP0005319_abnormal_enzyme/_coenzyme | 0.98755238 |
| 43 | MP0000230_abnormal_systemic_arterial | 0.98194424 |
| 44 | MP0002971_abnormal_brown_adipose | 0.97360920 |
| 45 | MP0003718_maternal_effect | 0.96752309 |
| 46 | MP0009642_abnormal_blood_homeostasis | 0.93748504 |
| 47 | MP0009764_decreased_sensitivity_to | 0.86452298 |
| 48 | MP0003011_delayed_dark_adaptation | 0.82997115 |
| 49 | MP0001663_abnormal_digestive_system | 0.79722720 |
| 50 | MP0003638_abnormal_response/metabolism_ | 0.79673325 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.79327763 |
| 52 | MP0008469_abnormal_protein_level | 0.71909123 |
| 53 | MP0003953_abnormal_hormone_level | 0.69162292 |
| 54 | MP0005376_homeostasis/metabolism_phenot | 0.68854032 |
| 55 | MP0005166_decreased_susceptibility_to | 0.65367145 |
| 56 | MP0005334_abnormal_fat_pad | 0.64772269 |
| 57 | MP0001485_abnormal_pinna_reflex | 0.64291453 |
| 58 | MP0001986_abnormal_taste_sensitivity | 0.64087399 |
| 59 | MP0005395_other_phenotype | 0.62161112 |
| 60 | MP0005409_darkened_coat_color | 0.61274482 |
| 61 | MP0005174_abnormal_tail_pigmentation | 0.60078456 |
| 62 | MP0010386_abnormal_urinary_bladder | 0.59552369 |
| 63 | MP0000477_abnormal_intestine_morphology | 0.59470242 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 0.59100658 |
| 65 | MP0003724_increased_susceptibility_to | 0.58490643 |
| 66 | MP0005381_digestive/alimentary_phenotyp | 0.58352698 |
| 67 | MP0002909_abnormal_adrenal_gland | 0.57481880 |
| 68 | MP0001845_abnormal_inflammatory_respons | 0.56820912 |
| 69 | MP0000598_abnormal_liver_morphology | 0.55176263 |
| 70 | MP0002822_catalepsy | 0.54683813 |
| 71 | MP0009785_altered_susceptibility_to | 0.54111551 |
| 72 | MP0000249_abnormal_blood_vessel | 0.53621791 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 0.52421387 |
| 74 | MP0001188_hyperpigmentation | 0.49094475 |
| 75 | MP0002069_abnormal_eating/drinking_beha | 0.48041704 |
| 76 | MP0009115_abnormal_fat_cell | 0.47572545 |
| 77 | MP0002638_abnormal_pupillary_reflex | 0.46433584 |
| 78 | MP0009763_increased_sensitivity_to | 0.46370308 |
| 79 | MP0005408_hypopigmentation | 0.46036953 |
| 80 | MP0001873_stomach_inflammation | 0.45717444 |
| 81 | MP0000604_amyloidosis | 0.44829654 |
| 82 | MP0003283_abnormal_digestive_organ | 0.43325772 |
| 83 | MP0008775_abnormal_heart_ventricle | 0.43259008 |
| 84 | MP0005464_abnormal_platelet_physiology | 0.42691280 |
| 85 | MP0005266_abnormal_metabolism | 0.42298021 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.41344098 |
| 87 | MP0002135_abnormal_kidney_morphology | 0.40967510 |
| 88 | MP0004885_abnormal_endolymph | 0.40524544 |
| 89 | MP0005645_abnormal_hypothalamus_physiol | 0.40390877 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.39367677 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.38063320 |
| 92 | MP0002098_abnormal_vibrissa_morphology | 0.36853840 |
| 93 | MP0000462_abnormal_digestive_system | 0.36485563 |
| 94 | MP0000566_synostosis | 0.35333810 |
| 95 | MP0000427_abnormal_hair_cycle | 0.34867067 |
| 96 | MP0000490_abnormal_crypts_of | 0.34410542 |
| 97 | MP0005367_renal/urinary_system_phenotyp | 0.33520528 |
| 98 | MP0000516_abnormal_urinary_system | 0.33520528 |
| 99 | MP0005187_abnormal_penis_morphology | 0.32163562 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.31889480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.60619687 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 6.28489645 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.11389577 |
| 4 | Complement deficiency (HP:0004431) | 5.19590032 |
| 5 | Abnormality of proline metabolism (HP:0010907) | 4.98123095 |
| 6 | Hydroxyprolinuria (HP:0003080) | 4.98123095 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.58095429 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 4.49315169 |
| 9 | Xanthomatosis (HP:0000991) | 4.32060658 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.21774901 |
| 11 | Fat malabsorption (HP:0002630) | 4.17467389 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.14840780 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.11694434 |
| 14 | Abnormality of complement system (HP:0005339) | 4.07023069 |
| 15 | Hyperglycinuria (HP:0003108) | 4.01532767 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.87990599 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 3.87990599 |
| 18 | Metabolic alkalosis (HP:0200114) | 3.87360338 |
| 19 | Glycosuria (HP:0003076) | 3.81589122 |
| 20 | Abnormality of urine glucose concentration (HP:0011016) | 3.81589122 |
| 21 | Deep venous thrombosis (HP:0002625) | 3.73457586 |
| 22 | Alkalosis (HP:0001948) | 3.73450932 |
| 23 | Malnutrition (HP:0004395) | 3.68156245 |
| 24 | Abnormality of vitamin metabolism (HP:0100508) | 3.62946249 |
| 25 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.52699620 |
| 26 | Abnormality of vitamin B metabolism (HP:0004340) | 3.50312586 |
| 27 | Proximal tubulopathy (HP:0000114) | 3.47437526 |
| 28 | Intrahepatic cholestasis (HP:0001406) | 3.39547123 |
| 29 | Glomerulonephritis (HP:0000099) | 3.36164546 |
| 30 | Hyperactive renin-angiotensin system (HP:0000841) | 3.31796931 |
| 31 | Generalized aminoaciduria (HP:0002909) | 3.30464459 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.23526622 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.19221456 |
| 34 | Epidermoid cyst (HP:0200040) | 3.10730459 |
| 35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.10217438 |
| 36 | Hyperammonemia (HP:0001987) | 3.09773890 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.02136605 |
| 38 | Widely patent fontanelles and sutures (HP:0004492) | 2.99568124 |
| 39 | Congenital sensorineural hearing impairment (HP:0008527) | 2.96489778 |
| 40 | Steatorrhea (HP:0002570) | 2.95283205 |
| 41 | Hyperglycinemia (HP:0002154) | 2.95057235 |
| 42 | Hyperphosphaturia (HP:0003109) | 2.94507980 |
| 43 | Decreased circulating renin level (HP:0003351) | 2.93453187 |
| 44 | Acanthocytosis (HP:0001927) | 2.93050044 |
| 45 | Potter facies (HP:0002009) | 2.92474815 |
| 46 | Facial shape deformation (HP:0011334) | 2.92474815 |
| 47 | Pigmentary retinal degeneration (HP:0001146) | 2.92323759 |
| 48 | Confusion (HP:0001289) | 2.91122664 |
| 49 | Abnormality of renin-angiotensin system (HP:0000847) | 2.91078260 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.85077002 |
| 51 | Nephritis (HP:0000123) | 2.77592531 |
| 52 | Chronic diarrhea (HP:0002028) | 2.76856774 |
| 53 | Joint hemorrhage (HP:0005261) | 2.76743200 |
| 54 | Ileus (HP:0002595) | 2.76450836 |
| 55 | Nausea (HP:0002018) | 2.76237909 |
| 56 | Abnormality of nucleobase metabolism (HP:0010932) | 2.74761943 |
| 57 | Metabolic acidosis (HP:0001942) | 2.72866878 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.62215223 |
| 59 | Abnormal urine phosphate concentration (HP:0012599) | 2.61383141 |
| 60 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.59636673 |
| 61 | Nephrolithiasis (HP:0000787) | 2.58701617 |
| 62 | Abnormality of magnesium homeostasis (HP:0004921) | 2.53710688 |
| 63 | Abnormality of serum amino acid levels (HP:0003112) | 2.46235284 |
| 64 | Vascular calcification (HP:0004934) | 2.41949453 |
| 65 | Increased circulating renin level (HP:0000848) | 2.40536600 |
| 66 | Rickets (HP:0002748) | 2.39294326 |
| 67 | Hyperuricemia (HP:0002149) | 2.37925234 |
| 68 | Increased purine levels (HP:0004368) | 2.37925234 |
| 69 | Hypokalemia (HP:0002900) | 2.33592486 |
| 70 | Cerebral palsy (HP:0100021) | 2.29415640 |
| 71 | Ketosis (HP:0001946) | 2.27569117 |
| 72 | Hyperaldosteronism (HP:0000859) | 2.24652354 |
| 73 | Hemorrhage of the eye (HP:0011885) | 2.24167869 |
| 74 | Hypophosphatemia (HP:0002148) | 2.24156725 |
| 75 | Lethargy (HP:0001254) | 2.22851123 |
| 76 | Hypomagnesemia (HP:0002917) | 2.21370208 |
| 77 | Megaloblastic anemia (HP:0001889) | 2.19530051 |
| 78 | Irritability (HP:0000737) | 2.18994935 |
| 79 | Focal segmental glomerulosclerosis (HP:0000097) | 2.16602264 |
| 80 | Poikilocytosis (HP:0004447) | 2.16202423 |
| 81 | Pancreatitis (HP:0001733) | 2.15661393 |
| 82 | Hypothermia (HP:0002045) | 2.15212046 |
| 83 | Abnormal urine output (HP:0012590) | 2.11074487 |
| 84 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.08576485 |
| 85 | Dicarboxylic aciduria (HP:0003215) | 2.08576485 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08565950 |
| 87 | Cardiovascular calcification (HP:0011915) | 2.07216703 |
| 88 | Gout (HP:0001997) | 2.06425734 |
| 89 | Abnormality of renal excretion (HP:0011036) | 2.05030202 |
| 90 | Hyperventilation (HP:0002883) | 2.04808400 |
| 91 | Abnormality of chloride homeostasis (HP:0011422) | 2.04058680 |
| 92 | Abdominal distention (HP:0003270) | 1.99479693 |
| 93 | Hypophosphatemic rickets (HP:0004912) | 1.96585111 |
| 94 | Osteomalacia (HP:0002749) | 1.96158870 |
| 95 | Spontaneous abortion (HP:0005268) | 1.93642331 |
| 96 | Hypoglycemic coma (HP:0001325) | 1.91754483 |
| 97 | Fair hair (HP:0002286) | 1.90306626 |
| 98 | Renal cortical cysts (HP:0000803) | 1.89060204 |
| 99 | Vomiting (HP:0002013) | 1.87223675 |
| 100 | Ketoacidosis (HP:0001993) | 1.86525833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.02890777 |
| 2 | FRK | 3.47479357 |
| 3 | WNK3 | 3.36563802 |
| 4 | OXSR1 | 3.20333105 |
| 5 | STK39 | 2.72271544 |
| 6 | ERN1 | 2.14773005 |
| 7 | ADRBK2 | 2.13656189 |
| 8 | PIK3CA | 2.13159029 |
| 9 | WNK4 | 2.05035773 |
| 10 | TAOK3 | 2.03180135 |
| 11 | GRK1 | 1.99254850 |
| 12 | PRKG2 | 1.90196708 |
| 13 | INSRR | 1.88406406 |
| 14 | MST1R | 1.84148068 |
| 15 | MAP4K2 | 1.70513116 |
| 16 | BMPR1B | 1.58405972 |
| 17 | CASK | 1.54315239 |
| 18 | AKT3 | 1.53587831 |
| 19 | EPHA3 | 1.45308790 |
| 20 | MST4 | 1.34407630 |
| 21 | PINK1 | 1.28406077 |
| 22 | EPHB2 | 1.25785821 |
| 23 | DAPK2 | 1.23141292 |
| 24 | TNIK | 1.21783836 |
| 25 | MYLK | 1.16325384 |
| 26 | MAPKAPK3 | 1.15704376 |
| 27 | TYK2 | 1.08302709 |
| 28 | PRKAA2 | 1.06960851 |
| 29 | RIPK1 | 1.06817579 |
| 30 | CAMKK2 | 1.06595447 |
| 31 | MAP3K12 | 1.05277013 |
| 32 | PIK3CG | 1.04346099 |
| 33 | PRKACG | 1.03562899 |
| 34 | MAP2K6 | 1.01815335 |
| 35 | TXK | 1.00942564 |
| 36 | IRAK1 | 0.98051592 |
| 37 | MAP3K2 | 0.97191883 |
| 38 | ERBB2 | 0.96036455 |
| 39 | EPHA4 | 0.94868138 |
| 40 | EPHA2 | 0.92686877 |
| 41 | MUSK | 0.91987732 |
| 42 | NLK | 0.91515337 |
| 43 | MATK | 0.89238836 |
| 44 | GRK6 | 0.83869609 |
| 45 | SGK2 | 0.81708389 |
| 46 | MAP2K2 | 0.80547030 |
| 47 | PDK2 | 0.78942644 |
| 48 | PRKCZ | 0.77730605 |
| 49 | SGK494 | 0.77722213 |
| 50 | SGK223 | 0.77722213 |
| 51 | FER | 0.76453137 |
| 52 | ADRBK1 | 0.76036397 |
| 53 | TEC | 0.74778501 |
| 54 | STK24 | 0.74194129 |
| 55 | PRKCA | 0.73115579 |
| 56 | MET | 0.72356275 |
| 57 | PRKCE | 0.71878027 |
| 58 | MAPK13 | 0.71645595 |
| 59 | PAK3 | 0.69998928 |
| 60 | NUAK1 | 0.67274352 |
| 61 | NTRK3 | 0.66322920 |
| 62 | MAPK15 | 0.64699023 |
| 63 | PTK6 | 0.64496314 |
| 64 | MAP3K4 | 0.62834504 |
| 65 | CSF1R | 0.62702124 |
| 66 | IGF1R | 0.62414076 |
| 67 | PRKACA | 0.61434178 |
| 68 | MAPK11 | 0.61336997 |
| 69 | FGFR3 | 0.59679741 |
| 70 | TESK2 | 0.59192183 |
| 71 | PRKCQ | 0.57736178 |
| 72 | MAP4K1 | 0.57419013 |
| 73 | TLK1 | 0.56612674 |
| 74 | CAMK2D | 0.54844494 |
| 75 | DYRK1B | 0.52963108 |
| 76 | KIT | 0.51167495 |
| 77 | SYK | 0.50525354 |
| 78 | MAP2K4 | 0.49359270 |
| 79 | BMPR2 | 0.47190583 |
| 80 | PRKG1 | 0.47017694 |
| 81 | PTK2B | 0.46434033 |
| 82 | PRKAA1 | 0.46388944 |
| 83 | IKBKE | 0.45591029 |
| 84 | CSNK1A1 | 0.44795892 |
| 85 | ITK | 0.41487134 |
| 86 | PRKCG | 0.41424786 |
| 87 | FGFR4 | 0.40768909 |
| 88 | IKBKB | 0.40454534 |
| 89 | PDPK1 | 0.40399918 |
| 90 | BRSK2 | 0.39536414 |
| 91 | BCKDK | 0.38424451 |
| 92 | ABL2 | 0.37836529 |
| 93 | MAP2K1 | 0.37248433 |
| 94 | STK16 | 0.36756747 |
| 95 | CHUK | 0.36656921 |
| 96 | PIM1 | 0.36006642 |
| 97 | PRKCD | 0.35767581 |
| 98 | CAMK2A | 0.35463772 |
| 99 | PDK1 | 0.35002638 |
| 100 | MAP3K10 | 0.34454511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.01371724 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.45269488 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.33222322 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.17468929 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.09635369 |
| 6 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.86731091 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.71174546 |
| 8 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.71123173 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.69976777 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.57093653 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.56508464 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.47351328 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.40467034 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39548207 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.31191314 |
| 16 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.28913495 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.15603965 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.06400990 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04922880 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.97181063 |
| 21 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.90826176 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.88301626 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.86162806 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.80592567 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.70738762 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.68330004 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.63946321 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63663260 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.61456194 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56780412 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.55068468 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.50908036 |
| 33 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.50761473 |
| 34 | Mineral absorption_Homo sapiens_hsa04978 | 1.39603095 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.36175807 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30890003 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.27940843 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.26673945 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.23097678 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.19715618 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.13910395 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.05100385 |
| 43 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.02701287 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98646097 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95221502 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93598777 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87948880 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.87108531 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.81669108 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78356181 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76414767 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74372634 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72336408 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72302943 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67124930 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66152290 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65562063 |
| 58 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59495046 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58450450 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56703220 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55972153 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54616682 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47915082 |
| 64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46345104 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42871395 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42738101 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40678572 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37872122 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.36938317 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33065291 |
| 71 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31370997 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30844128 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30457245 |
| 74 | Asthma_Homo sapiens_hsa05310 | 0.29383644 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25908473 |
| 76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.24826467 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.24523276 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24060705 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.24030935 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.23392814 |
| 81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.22130375 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21537048 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.17215618 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.12743558 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12562247 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12322385 |
| 87 | Insulin secretion_Homo sapiens_hsa04911 | 0.12174862 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08421311 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.07790271 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.06096428 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.05642538 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.05479616 |
| 93 | Cocaine addiction_Homo sapiens_hsa05030 | 0.04082232 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.03757886 |
| 95 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.03330738 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.02854455 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.02235166 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.02088873 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.01410738 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | -0.0474466 |

